The diagnosis that followed was one that millions of men fear: aggressive prostate cancer. He became the very first patient to enroll in the PRELUDE Trial, a groundbreaking clinical study aimed at preventing recurrence. He recently attended a high school reunion where he met a former classmate who had gone through a similar prostate cancer diagnosis. “We are eager to see if this promising therapy improves patient outcomes in men with high-risk localized prostate cancer,” Dr. Yerram stated. This Prostate Cancer Awareness Month, please consider sharing the news of this crucial trial.